Cargando…
Shenlijia Attenuates Doxorubicin-Induced Chronic Heart Failure by Inhibiting Cardiac Fibrosis
Application of the anticancer drug doxorubicin (DOX) is restricted due to its adverse, cardiotoxic side effects, which ultimately result in heart failure. Moreover, there are a limited number of chemical agents for the clinical prevention of DOX-induced cardiotoxicity. Based on the theories of tradi...
Autores principales: | Sun, Xutao, Song, Yunjia, Xie, Ying, Han, Jieru, Chen, Fei, Sun, Yang, Sui, Bowen, Jiang, Deyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310442/ https://www.ncbi.nlm.nih.gov/pubmed/34326887 http://dx.doi.org/10.1155/2021/6659676 |
Ejemplares similares
-
Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats
por: Sun, Xutao, et al.
Publicado: (2020) -
Zisheng Shenqi Decoction Ameliorates Monosodium Urate-Mediated Gouty Arthritis in Rats via Promotion of Autophagy through the AMPK/mTOR Signaling Pathway
por: Han, Jieru, et al.
Publicado: (2021) -
Atractylenolide III Improves Mitochondrial Function and Protects Against Ulcerative Colitis by Activating AMPK/SIRT1/PGC-1α
por: Han, Jieru, et al.
Publicado: (2022) -
Alarin alleviated cardiac fibrosis via attenuating oxidative stress in heart failure rats
por: Li, Jinshuang, et al.
Publicado: (2021) -
Targeted inhibition of Focal Adhesion Kinase Attenuates Cardiac Fibrosis and Preserves Heart Function in Adverse Cardiac Remodeling
por: Zhang, Jie, et al.
Publicado: (2017)